These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008 [TBL] [Abstract][Full Text] [Related]
25. Improving diagnostic performance of Yang DD; Mirvis E; Goldring J; Patel ARC; Wagner T Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186 [TBL] [Abstract][Full Text] [Related]
26. Diffusion-weighted imaging vs STIR turbo SE imaging: capability for quantitative differentiation of small-cell lung cancer from non-small-cell lung cancer. Koyama H; Ohno Y; Nishio M; Takenaka D; Yoshikawa T; Matsumoto S; Seki S; Maniwa Y; Ito T; Nishimura Y; Sugimura K Br J Radiol; 2014 Jun; 87(1038):20130307. PubMed ID: 24786147 [TBL] [Abstract][Full Text] [Related]
27. The lung cancers: staging and response, CT, Owens C; Hindocha S; Lee R; Millard T; Sharma B Br J Radiol; 2023 Aug; 96(1148):20220339. PubMed ID: 37097296 [TBL] [Abstract][Full Text] [Related]
28. Predictive Value of Zhang A; Meng X; Yao Y; Zhou X; Yan S; Fei W; Zhou N; Zhang Y; Kong H; Li N J Magn Reson Imaging; 2023 May; 57(5):1367-1375. PubMed ID: 36066210 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of Amide Proton Transfer-Weighted Imaging for Lung Cancer Subtype and Epidermal Growth Factor Receptor: A Comparative Study With Diffusion and Metabolic Parameters. Meng N; Fu F; Feng P; Li Z; Gao H; Wu Y; Zhang J; Wei W; Yuan J; Yang Y; Liu H; Cheng J; Wang M J Magn Reson Imaging; 2022 Oct; 56(4):1118-1129. PubMed ID: 35258145 [TBL] [Abstract][Full Text] [Related]
30. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study. Zhai X; Guo Y; Qian X Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109 [TBL] [Abstract][Full Text] [Related]
32. Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer. Alongi F; Ragusa P; Montemaggi P; Bona CM Tumori; 2006; 92(4):327-33. PubMed ID: 17036525 [TBL] [Abstract][Full Text] [Related]
33. The diagnostic ability of Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133 [TBL] [Abstract][Full Text] [Related]
34. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study. Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896 [TBL] [Abstract][Full Text] [Related]
35. Prospective comparison of Kirchner J; Sawicki LM; Nensa F; Schaarschmidt BM; Reis H; Ingenwerth M; Bogner S; Aigner C; Buchbender C; Umutlu L; Antoch G; Herrmann K; Heusch P Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):437-445. PubMed ID: 30074073 [TBL] [Abstract][Full Text] [Related]
36. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
37. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906 [TBL] [Abstract][Full Text] [Related]
38. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease. An YS; Sun JS; Park KJ; Hwang SC; Park KJ; Sheen SS; Lee S; Lee KB; Yoon JK Lung; 2008; 186(5):327-36. PubMed ID: 18670805 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the diagnostic accuracy of diffusion-weighted and dynamic contrast-enhanced MRI with Diez AIG; Fuster D; Morata L; Torres F; Garcia R; Poggio D; Sotes S; Del Amo M; Isern-Kebschull J; Pomes J; Soriano A; Brugnara L; Tomas X Eur J Radiol; 2020 Nov; 132():109299. PubMed ID: 33032207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]